Healthcare -
Biotechnology - NASDAQ - US
$ 7.78
-1.02 %
$ 43.5 M
Market Cap
None
P/E
TNXP - COST OF REVENUE
Cost of Revenue TNXP - Tonix Pharmaceuticals Holding Corp.
4.74 M
LAST VALUE
-77.34%
2 YEAR CAGR
-29.02%
5 YEAR CAGR
-7.98%
10 YEAR CAGR